300039.SZ
Shanghai Kaibao Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 5.29
−4.51%Margins
Gross margin
80.3%
EBITDA margin
34.8%
EBIT margin
28.9%
Net margin
25.0%
FCF margin
16.1%
5.5%
Return on equity
5.1%
Return on assets
6.4%
Return on invested capital
0.21x
Asset turnover
CNY 189.7M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026